Maged Shenouda Acquires 6,875 Shares of Relmada Therapeutics

Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) CFO Maged Shenouda acquired 6,875 shares of Relmada Therapeutics stock in a transaction dated Wednesday, January 31st. The stock was bought at an average price of $4.06 per share, with a total value of $27,912.50. Following the completion of the purchase, the chief financial officer now directly […]

Related Keywords

Alger , Algeria , Maged Shenouda , Relmada Therapeutics Inc , Advisor Group Holdings Inc , Ameritas Investment Partners Inc , Fred Alger Management , Relmada Therapeutics Company Profile , Nasdaq , Relmada Therapeutics , Get Free Report , Therapeutics Stock Down , Financial Advisors , Investment Partners , Group Holdings , Relmada Therapeutics Daily , Nasdaq Rlmd , Rlmd , Medical , Insider Trading , Nsider Trades , Stocks ,